Intensive Review of Nephrology 2020

Intensive Review of Nephrology 2020

Regular price€50,00
/
Tax included. Shipping calculated at checkout.

  • Free Shipping on orders over 45$
  • In stock, ready to ship
  • Inventory on the way
[

Intensive Review of Nephrology 2020 The target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Learning Objectives


After viewing this program, participants will be better able to:
  • Summarize current/recommended nephrology guidelines in clinical practice
  • Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
  • Identify/integrate current therapeutic options for specific renal disorders
  • Review and interpret up-to-date literature relevant to clinical practice
  • Describe pathophysiological mechanisms as they apply to management of renal disease
  • Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

ACGME Competencies


 

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:
  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Practice-Based Learning and Improvement
  • Target Audience

The target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Topics And Speakers:
Glomerulonephritis

  • Renal Physiology for the Boards – Melanie P. Hoenig, MD
  • Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD
  • Renal Pathology in 2020: Part 1 – Helmut G. Rennke, MD
  • Renal Pathology in 2020: Part 2 – Astrid Weins, MD, PhD
  • Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD
  • IgA Nephropathy – Gerald B. Appel, MD
  • Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
  • ANCA Vasculitis – John L. Niles, MD
  • Update on Lupus Nephritis – Gerald B. Appel, MD
  • Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
  • Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
  • Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD
  • Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA
  • Must-Know Board Zebra – Emily Robinson, MD, MPH
  • Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI
  • Nephrology Board Review Practice 2 – Mallika Mendu, MD

Electrolytes and Acid Base

  • Workshop: Hyponatremia and Hypernatremia – David B. Mount, MD
  • Hypokalemia and Hyperkalemia – David B. Mount, MD
  • Acid-Base Part I – Acidosis – Alan S.L. Yu, MB, BChir
  • Acid-Base Part II – Alkalosis – Alan S.L. Yu, MB, BChir
  • COVID-19 and Kidney Disease – Daniel Batlle, MD
  • Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
  • Update on Polycystic Kidney Disease – Cristian Riella, MD
  • Pediatric Nephrology – Michael J.G. Somers, MD
  • Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH
  • Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 1 – Alan S.L. Yu, MB, BChir
  • Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 2 – Alan S.L. Yu, MB, BChir
  • Chronic Kidney Disease in the Community: Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP

Transplantation

  • Why Do We Reject a Transplant? – Jamil R. Azzi, MD
  • Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
  • Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
  • Early Post-Transplant Management – Anil K. Chandraker, MD
  • Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD
  • Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD
  • Infections in Transplant Recipients – Sarah P. Hammond, MD
  • COVID-19 and Transplant Patients – Enver Akalin, MD, FAST, FASN
  • Renal Transplant Recipient Medical Evaluation – Jamil R. Azzi, MD
  • Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS
  • Donor Evaluation – Kassem Safa, MD
  • Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
  • Thrombotic Microangiopathies – Jean M. Francis, MD
  • Geriatric Nephrology – Ernest I. Mandel, MD
  • Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD, and Edgar L. Milford, MD
  • Transplant Board Review – Leonardo V. Riella, MD, PhD
  • CKD and General Nephrology
  • Update on Renovascular Disease – Joseph M. Garasic, MD
  • Management of Hypertension after SPRINT – Richard J. Glassock, MD
  • Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
  • Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
  • Liver and the Kidney – Andrew S. Allegretti, MD, MSc

Acute Kidney Injury

  • Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
  • Acute Kidney Injury Syndromes – Alice Sheridan, MD
  • ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
  • COVID-19 in the ICU – Jeremy B. Richards, MD
  • Cancer and Acute Kidney Injury – Albert Q. Lam, MD
  • Paraprotein Induced Kidney Injury – Albert Q. Lam, MD
  • FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD
  • Interstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH
  • APOL1 and Kidney Disease – Martin R. Pollak, MD

Dialysis

  • Dialysis Dosing – J. Kevin Tucker, MD
  • Mineral and Bone Disease – David Bushinsky, MD
  • Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
  • Pearls in Mineral and Bone Disease – David Bushinsky, MD
  • Chronic Kidney Disease Epidemiology: A 2019 Update – Gearoid M. McMahon, MB BCh
  • Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
  • Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC
  • COVID-19 and Patients on Dialysis – Giuliano Brunori, MD
  • Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
  • Dialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD

Reviews

There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.

]

- Orders under 45$ will have a shipping charge of a flat rate of 15$.

-Orders over 45$ will have Free Shipping.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Testimonials

★★★★★


“I find the taste of Moringa tea to be very refreshing and it definitely gives me a feeling of ‘wellness’. I appreciate the ethics of the company. Am looking forward to trying the cream”

Elain
★★★★★


”I love knowing that everything is 100% chemical-free and tested in Canada. I also respect the sustainable farming approach that supports both Canada and Ethiopia.”

Alycia
★★★★★

Since I drink Moringa Tea I feel so much better. My mouth was always so dry but since I drink this tea I have so much saliva I drool.

I cannot believe how much it has helped me with my breathing. I love it. I even eat all the leaves - Thank you for introducing me to this herbal tea. I'm 85 years old.

Richard Dorge
Winnipeg, MB

Recently viewed